BANOOK CONTRIBUTES TO THE DREAM PROJECT: SHAPING THE FUTURE OF BIOMEDICAL INNOVATION

The project DREAM, co-financed by the European Union and Grand Est region, brings together academic researchers and industry experts to design next-generation biomedical devices. By combining 3D/4D printing, biomimetic materials, and artificial intelligence, DREAM aims to revolutionize how medical technologies are conceived, produced, and applied in clinical practice.
👉 Learn more about the project here

What Is the DREAM Project?

DREAM (Device for Regenerative, Emerging and Advanced Medicine) is a large-scale European and local initiative led by the Université de Lorraine, uniting scientists, engineers, and industrial partners around a shared ambition: to develop bio-inspired, personalized and durable medical devices that can improve patients’ quality of life.

The project focuses on several major areas of application:

• Orthopedics, rehabilitation, and re-education

• Cranio-maxillofacial, oral, and reconstructive surgery

• Cardiology and thoracic surgery

Through a multidisciplinary approach—spanning biomaterial design, 3D/4D printing, digital modeling, and validation phases (in silico, in vitro, ex vivo, and in vivo), the project explores how advanced materials and digital tools can accelerate medical innovation and clinical translation.

Banook’s Role in DREAM

Within DREAM, Banook has been actively involved in the cardiovascular research axis, contributing its expertise in cardiac monitoring and digital health solutions.

This includes exploratory work on innovative approaches to non-invasive ECG monitoring and the integration of artificial intelligence for arrhythmia detection and personalized follow-up. These developments could, in time, help enhance patient comfort, data accuracy and remote-care capabilities in cardiovascular medicine.

A Collaborative Local and European Effort

DREAM brings together a broad consortium of partners including:

• Université de Lorraine / IUT Nancy-Brabois (project lead)

• Caremosim, Cybernano, SimplySim, Banook, and several academic and clinical teams

This network of expertise bridges fundamental research, digital technologies and industrial innovation, an essential combination for moving promising concepts from lab to market.

Why DREAM Matters

The project’s ambition reaches far beyond individual applications. By merging materials science, engineering and AI, DREAM paves the way for custom-made, sustainable medical solutions that respond directly to patient needs.

For cardiovascular research, the potential is particularly significant: smarter monitoring systems, improved long-term follow-up, and a more connected vision of healthcare supported by data intelligence.

European Union Co-financing

This initiative is co-financed by the Grand Est region and European Union, reflecting Europe’s ongoing commitment to research, innovation and cross-border collaboration in healthcare.

Total cost of the operation: €2,485,964.95

Funded by the European Union to the tune of €1,491,579

Looking Ahead

As DREAM continues, the consortium’s results will help define how future medical devices are designed and validated—combining scientific excellence, technological innovation and clinical relevance.

Through its participation, Banook contributes to this shared vision of local and European innovation: building smarter, more sustainable and more human-centred health technologies.